| 产品名称 | 15N Beta-Amyloid (11-40), Uniformly labeled - 1.0 mg（rPeptide） |
|---|---|
| 目录号 | A-1137-1 |
| 别名 | 15N Beta-Amyloid (11-40), Uniformly labeled |
| 外观 | N/A |
| 分子量 | 3188.72 Da |
| CAS | N/A |
| 溶解度 | N/A |
| 存储条件 | -20℃ |
| 保存时间 | 见标签 |
| 备注1 | Purity：>97% |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| A-1137-1 | 1.0 mg | 请咨询客服 | 请咨询客服 |
品名: 15N Beta-Amyloid (11-40), Uniformly labeled
货号: A-1137-1
规格: 1.0 mg
品牌：rPeptide
储存温度：-20℃
序列：E V H H Q K L V F F A E D V G S N K G A I I G L M V G G V V
来源：Recombinant. A DNA sequence encoding the human beta-amyloid (11-40) sequence was expressed in E. coli with N15 as the nitrogen source.
描述：Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). Alzheimer’s diseased brains show significant levels of Abeta (11-40) and Abeta (11-42). The ß-secretase enzyme or ß- amyloid precursor protein-cleaving enzyme (BACE) generates the N terminus of Aß, producing full-length Abeta (1-40 and 1-42) and/or truncated Abeta (11-40 and 11-42). The abundance of Abeta (11-40 and 11-42) produced by BACE suggests that they might be playing an important role in Alzheimer’s disease pathogenesis.
分子量：3188.72 Da
纯度：>97%
